IMC Chicago
LABD icon

IMC Chicago’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

IMC Chicago’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716K Buy
43,900
+20,600
+88% +$390K ﹤0.01% 3628
2025
Q4 		$491K Buy
+23,300
New +$632K ﹤0.01% 3497

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IMC Chicago's LABD Position: Q1 2026 in Review

IMC Chicago opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026: 12,486 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #4994 among its holdings. This is a return to the name: IMC Chicago previously reported a position in LABD as recently as Q4 2023.

IMC Chicago first reported a position in LABD in Q3 2019 and has held it in 6 quarters since. The position peaked at $3.45M in Q4 2019. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • IMC Chicago held 12,486 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $204K as of Q1 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new IMC Chicago position in Q1 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4994 holding.
  • IMC Chicago first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2019 and has held it in 6 quarters since.
  • IMC Chicago's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $3.45M in Q4 2019.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.